PPD’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.
PPD has vast experience and expertise in infectious diseases studies, combined with a large investigator network and microbiology labs.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
Download PPD's white paper Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations to learn how to position your company for success with biosimilar development in emerging regions.
View all of PPD's news releases.
CenterWatch 2013 Global Investigative Site Survey results place PPD at top of CRO field.
Donna Hellsten, vice president of clinical development, discusses the growth of clinical trials in Latin America.
Join leading experts to learn how to address patient adherence issues in asthma trials in real-world settings.
Michael Clay, vice president of clinical development, highlights PPD’s capabilities across Asia Pacific.
Roger Newbery, vice president of clinical management, discusses clinical research in Europe, Middle East and Africa.
Join leading experts to learn the benefits and successful outcomes of adaptive designs in oncology trials.
Explore job opportunities around the world to advance your career.
PPD has the resources to help you deliver your product to market.
© 2013 Pharmaceutical Product Development, LLC. All rights reserved.
